weight loss/obesity

FIELD OF THE INVENTION The present invention relates to a composition comprising polyisoprenylated benzophenone derivative and at least one component selected from stilbene derivative and anthocyanins. More specifically, the composition of the present invention comprise garcinol/guttiferones and at

CROSS-REFERENCE TO RELATED APPLICATION This application is the National Phase of International Patent Application No. PCT/NL2013/050411, filed Jun. 10, 2013 published on Dec. 18, 2014 as WO 2014/200332 A1, which is hereby incorporated by reference in its entirety. The invention rests in the field of

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is directed to a method of losing weight which is rapid, safe, easy to use and implement, and effective for the treatment of an individual suffering from obesity. Predetermined nutrients high in protein are administered through a

BACKGROUND OF THE INVENTION The present invention relates to a process and product for promoting weight loss in overweight dogs, and more particularly to a process for supplementing a canine diet with L-carnitine to promote weight loss, improve body composition, and enhance satiety in the animal. It

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the field of weight reduction and maintenance of body weight. More specifically, the present invention provides a composition that is particularly suited for the long term management of weight in general, and

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

FIELD OF THE INVENTION The present invention relates to transdermal devices and methods for controllable dispensing of a nutraceutical or an active substance such as a chemical substance, a medication, a drug, a stimulant or the like, to a human or other mammal for purposes of promoting longevity,

BACKGROUND OF THE INVENTION The prevalence of obesity in both children and adults is on the rise in first world countries, especially in the United States, as well as in many developing countries such as China and India. Many aspects of a person's life are affected by obesity, from physical problems

BACKGROUND OF THE INVENTION The prevalence of obesity in both children and adults is on the rise in first world countries, especially in the United States, as well as in many developing countries such as China and India. Many aspects of a person's life are affected by obesity, from physical problems

BACKGROUND OF THE INVENTION The prevalence of obesity in both children and adults is on the rise in first world countries, especially in the United States, as well as in many developing countries such as China and India. Many aspects of a person's life are affected by obesity, from physical problems

FIELD OF INVENTION The invention relates to a method for treating overweight individuals or patients with obesity using a food composition able to control the release of glucose into the patient's blood. This is achieved by the introduction into the food composition of a hydrophilic food grade

FIELD OF THE INVENTION The present invention relates to pharmaceutical compositions, whose mechanisms of action(s) are at the kainate/AMPA receptor that can be used to treat the medical condition of obesity. BACKGROUND OF THE INVENTION Obesity is one of the most common medical disorders, which